HomeMOR • ETR
add
MorphoSys AG
Nakaraang pagsara
€67.65
Sakop ng araw
€67.65 - €68.00
Sakop ng taon
€14.52 - €69.75
Market cap
2.55B EUR
Average na Volume
66.52K
P/E ratio
-
Dividend yield
-
Primary exchange
ETR
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (EUR) | Mar 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 27.54M | 13.11% |
Gastos sa pagpapatakbo | 289.14M | 264.02% |
Net na kita | -314.96M | -608.87% |
Net profit margin | -1.14K | -526.67% |
Kita sa bawat share | -8.27 | -529.19% |
EBITDA | -263.38M | -388.32% |
Aktuwal na % ng binabayarang buwis | 0.51% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (EUR) | Mar 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 630.77M | -20.30% |
Kabuuang asset | 1.83B | -17.85% |
Kabuuang sagutin | 2.09B | -1.84% |
Kabuuang equity | -261.67M | — |
Natitirang share | 37.62M | — |
Presyo para makapag-book | -9.72 | — |
Return on assets | -34.27% | — |
Return on capital | -41.11% | — |
Cash Flow
Net change in cash
| (EUR) | Mar 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -314.96M | -608.87% |
Cash mula sa mga operasyon | -71.53M | 14.27% |
Cash mula sa pag-invest | 28.62M | 187.62% |
Cash mula sa financing | -950.28K | 97.86% |
Net change in cash | -27.24M | 75.37% |
Malayang cash flow | 246.91M | 1,523.66% |
Tungkol
MorphoSys AG is a German biopharmaceutical company founded in 1992. The company is headquartered near Munich, Germany, and has a wholly owned subsidiary, MorphoSys US Inc., in Boston, Massachusetts, in the US. The company has various antibody, protein and peptide technologies that it uses to discover and develop both proprietary and partnered drug candidates. The company has more than 100 drugs in its wider pipeline that are being investigated for a variety of diseases. While many of these are being developed in partnership with pharma and biotech companies, MorphoSys also has a proprietary pipeline with a focus on cancer and autoimmune diseases.
MorphoSys AG is listed on the Frankfurt Stock Exchange and on the US Nasdaq stock exchange. Novartis agreed to acquire the company in February 2024. Wikipedia
Itinatag
1992
Headquarters
Website
Mga Empleyado
464
